GLP-1 drugs need to be reframed in the public mind as an essential medical treatment rather than ‘skinny jabs’, say ...

The company is one of two major players in the rapidly growing obesity drug market. Yet, the stock has lost half its value.

During menopause, women often deal with biological, physical, and emotional issues — to help them lose weight, clinicians ...

Knowable Magazine reports on the challenges faced by constitutionally thin individuals, who struggle to gain weight despite ...

It may seem rather comical that a guy with hardly any hair is writing an article about how to take care of and optimize your ...

Oklahoma has grit, resources and momentum. The question is whether we’ll build the pillars necessary to keep it going.

Testosterone is the primary androgen — or male hormone — in your body. Low testosterone affects up to 39 percent ...

A group of scientists has found that severe obesity accelerates lung aging. This may explain the breathing problems in ...

In a world where slimness is often equated with health, a new Danish study has flipped the narrative: being slightly ...

Sitting all day might seem harmless but expert warns that it could quietly put you at risk of blood clots Read ahead to know how to protect yourself before your body pays the price ...

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Eli Lilly and Novo Nordisk dominate the weight-loss market. Yet Pfizer, Roche and others are scooping up new drugs in a bid ...